These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 31748189

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Tailored risk assessment of 90-day acute heart failure readmission or all-cause death to heart failure with preserved versus reduced ejection fraction.
    Park J, Zhong X, Babaie Sarijaloo F, Wokhlu A.
    Clin Cardiol; 2022 Apr; 45(4):370-378. PubMed ID: 35077583
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
    Prasada S, Shah SJ, Michos ED, Polak JF, Greenland P.
    Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
    [Abstract] [Full Text] [Related]

  • 29. Patient characteristics, short-term and long-term outcomes after incident heart failure admissions in a regional Australian setting.
    Al-Omary MS, Majeed T, Al-Khalil H, Sugito S, Clapham M, Ngo DTM, Attia JR, Boyle AJ, Sverdlov AL.
    Open Heart; 2022 May; 9(1):. PubMed ID: 35641098
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A, Saad M, Saksena S.
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [Abstract] [Full Text] [Related]

  • 34. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH, Benson L, Dahlström U, Edner M, Friberg L.
    JAMA; 2014 Nov 19; 312(19):2008-18. PubMed ID: 25399276
    [Abstract] [Full Text] [Related]

  • 35. Characteristics and outcomes of heart failure in Japan: A hospital-based administrative database analysis.
    Ono Y, Yoneda K, Okuyama N, Nagai T.
    ESC Heart Fail; 2024 Sep 03. PubMed ID: 39226214
    [Abstract] [Full Text] [Related]

  • 36. Comparable effect of tolvaptan in heart failure patients with preserved or reduced ejection fraction.
    Kiuchi S, Hisatake S, Kabuki T, Oka T, Dobashi S, Fujii T, Ikeda T.
    Clin Exp Hypertens; 2020 Sep 03; 42(2):110-117. PubMed ID: 30793983
    [Abstract] [Full Text] [Related]

  • 37. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U, Dahlström U, Fu M, Lund LH.
    JACC Heart Fail; 2017 Aug 03; 5(8):565-574. PubMed ID: 28711451
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J, Díez-López C, de Antonio M, Domingo M, Zamora E, Moliner P, González B, Santesmases J, Troya MI, Bayés-Genís A.
    Eur J Heart Fail; 2017 Dec 03; 19(12):1615-1623. PubMed ID: 28387002
    [Abstract] [Full Text] [Related]

  • 40. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
    Tromp J, Khan MA, Klip IT, Meyer S, de Boer RA, Jaarsma T, Hillege H, van Veldhuisen DJ, van der Meer P, Voors AA.
    J Am Heart Assoc; 2017 Mar 30; 6(4):. PubMed ID: 28360225
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.